We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
An SI Board Since October 1996
Posts SubjectMarks Bans Symbol
714 2 0 HPRT
Emcee:  George Holt Type:  Unmoderated
Heartport recieved FDA approval today for its long awaited less invasive heart bypass procedure. I bought in at 35 1/8 with the stock already up 5 points. I will be looking for the stocj=k to hopefully reach new highs soon (over 43). This could be very soon with good media coverage.

Here is the press release:

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Oct. 7, 1996--Heartport,
Inc. (Nasdaq: HPRT), announced today that it received clearance from
the U.S. Food and Drug Administration (FDA) to market the Company's
Endovascular Cardiopulmonary Bypass (EndoCPB(TM)) System. The
EndoCPB System is a proprietary set of catheters, cannulae, and other
devices that permit a patient's heart to be stopped and protected,
and the patient to be safely maintained on cardiopulmonary bypass
during heart surgery, without the need to crack open the chest.

The Company also received pre-market notification exemptions from
the FDA, clearing its core reusable and disposable surgical devices
to be labeled and used for minimally invasive cardiovascular
surgery. These devices are integral to Heartport's Port-Access(TM)
CABG and Port-Access MVR Systems for heart surgery.

"We are very pleased that we have cleared these regulatory
hurdles," said Wesley D. Sterman, MD, Heartport's president and
chief executive officer. "The FDA action enables us to label and use
our systems explicitly for minimally invasive heart surgery, and
should allow us to launch our systems in the United States as much
as a year earlier than we previously expected."

Heartport also announced that, over the next month, it will begin
its clinical training program at leading U.S. medical centers,
including Barnes-Jewish Hospital at Washington University in St.
Louis, Brigham and Women's Hospital, The Cleveland Clinic Foundation,
Johns Hopkins, New York University, and Stanford University.

In preparation for its full-scale market launch, Heartport will
provide its core Port-Access CABG and Port-Access MVR Systems to the
medical centers leading its clinical training program. This will
enable these centers both to perform Port-Access heart surgery and
to train surgical teams from other leading medical centers. The
Company currently plans to make its complete Port-Access CABG and
Port-Access MVR Systems commercially available in the United States
by mid-1997, after it has scaled up its training and manufacturing,
and subject to receipt of FDA clearances for additional Port-Access

Heartport's Port-Access Systems are designed to allow surgeons to
perform a wide range of heart operations, including coronary artery
bypass grafting (CABG) and mitral valve replacement and repair (MVR),
through small incisions, or "ports," between the ribs, eliminating
the need to crack open the chest. The Company believes that its
systems may reduce the trauma, complications, and pain associated
with open-heart surgery, shorten hospital stays, reduce recovery
time, and lower overall costs.

Heartport, Inc., is a cardiovascular device company developing
minimally invasive Port-Access approaches to major heart surgery,
including coronary artery bypass grafting and heart valve replacement
and repair.

Note: Except for the historical information contained herein,
this press release contains forward-looking statements, the accuracy
of which are necessarily subject to risks and uncertainties. Actual
events or results may differ materially due to factors set forth from
time to time in the Company's filings with the Securities and
Exchange Commission, including its prospectus dated April 25, 1996.

--30--jf/sf* ap/gdr/sf

CONTACT: Heartport, Inc.

Jim Weiss, 415/482-4430


PHOTO: 1007bw2

REPEATS: New York 212-752-9600 or 800-221-2462; Boston 617-236-4266 or
800-225-2030; SF 415-986-4422 or 800-227-0845; LA 310-820-9473

Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
714Glad to hear from you, Peter. Not much new with me -- don't check into SI thBob Jagow-10/8/2000
713Bob - long time...hope all is well. Like you (I expect) hprt fell off my radar PeterR1700-10/4/2000
712 Thanks Pasaul William William H. Ferguson-1/30/2000
711 Look at the latest news and earning report on Yahoo.Pasaul-1/29/2000
710 So what's up? WilliamWilliam H. Ferguson-12/29/1999
709 To all; Anybody know the particulars of the annual shareholders meeting? TIA&gDavid Bogdanoff-5/26/1999
708 The WSJ article was widely circulated. The heart surgeons have all but given uWTDG-5/18/1999
707 Bankrupt? Maybe, but not anytime soon, they have plenty of cash still. regardHarpo-5/15/1999
706 Hi WTDG[my favorite station :)], Word on the "Street" is that HPRT isBob Jagow-5/15/1999
705 My understanding is that they are selling a new model. John McDonald-5/15/1999
704 That means that they are selling nothing. This company really blew it. WTDG-5/14/1999
703 OK...this morning I spoke to my broker who called HPRT again. HPRT reiterated John McDonald-5/12/1999
702 I can not be more specific regarding "older model" v "newer modeJohn McDonald-5/11/1999
701 Can you please be more specific. "older model" v "newer model&qWTDG-5/11/1999
700 What are you refering to? Again I thought the news was about an older obsoleteJohn McDonald-5/9/1999
699 There are going to be so many lawsuits on this. Either patients suing the physWTDG-5/9/1999
698 As I understand it, that is old news regarding earlier model. John McDonald-5/6/1999
697 Yes, nothing we didn't already know, although now everyone else does too. Harpo-5/6/1999
696 Anyone see yesterday's front-page Wall Street Journal HPRT story? Pretty dCheeseburger-5/6/1999
695 The main issue is still cost. Unless HPRT can demonstrate dramatic cost savingWTDG-4/25/1999
694 HPRT today announced several product improvements. I am asking people with tecjonathan romanowsky-4/19/1999
693 slight downgrade today eom Harpo-4/13/1999
692 This is still true... Actually, OR costs are around $100 per minute or $6000 pWTDG-4/1/1999
691 I have heard that there is so much setup time for HPRT procedure, , that this oPierre Borczuk-4/1/1999
690 I think that there has been some speculation that HPRT would eventually take ofWTDG-3/31/1999
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):